The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $4.29 in the prior trading day, GoodRx Holdings Inc (NASDAQ: GDRX) closed at $4.28, down -0.23%. In other words, the price has decreased by -$0.23 from its previous closing price. On the day, 2.3 million shares were traded. GDRX stock price reached its highest trading level at $4.3 during the session, while it also had its lowest trading level at $4.15.
Ratios:
Our goal is to gain a better understanding of GDRX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.85. For the most recent quarter (mrq), Quick Ratio is recorded 4.21 and its Current Ratio is at 4.21. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.84.
Raymond James Upgraded its Outperform to Strong Buy on August 09, 2024, while the target price for the stock was maintained at $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 03 ’25 when Spectrum Equity VII, L.P. sold 10,677 shares for $4.80 per share. The transaction valued at 51,226 led to the insider holds 0 shares of the business.
Spectrum VII Investment Manage bought 6,828 shares of GDRX for $32,160 on Jul 03 ’25. On Jul 03 ’25, another insider, Spectrum VII Co-Investment Fun, who serves as the Affiliate of the company, bought 3,849 shares for $4.71 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GDRX now has a Market Capitalization of 1492299136 and an Enterprise Value of 1753305984. As of this moment, GoodRx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 46.12, and their Forward P/E ratio for the next fiscal year is 9.46. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.86 while its Price-to-Book (P/B) ratio in mrq is 2.35. Its current Enterprise Value per Revenue stands at 2.192 whereas that against EBITDA is 13.025.
Stock Price History:
The Beta on a monthly basis for GDRX is 1.24, which has changed by -0.4448768 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, GDRX has reached a high of $8.16, while it has fallen to a 52-week low of $3.31. The 50-Day Moving Average of the stock is -5.69%, while the 200-Day Moving Average is calculated to be -5.59%.
Shares Statistics:
The stock has traded on average 2.92M shares per day over the past 3-months and 2689540 shares per day over the last 10 days, according to various share statistics. A total of 99.90M shares are outstanding, with a floating share count of 81.17M. Insiders hold about 76.64% of the company’s shares, while institutions hold 15.77% stake in the company. Shares short for GDRX as of 1755216000 were 5365209 with a Short Ratio of 1.84, compared to 1752537600 on 5516302. Therefore, it implies a Short% of Shares Outstanding of 5365209 and a Short% of Float of 6.140000000000001.
Earnings Estimates
As of right now, 12.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.1, with high estimates of $0.11 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.4 and $0.34 for the fiscal current year, implying an average EPS of $0.38. EPS for the following year is $0.46, with 12.0 analysts recommending between $0.51 and $0.39.
Revenue Estimates
12 analysts predict $195.17M in revenue for the current quarter. It ranges from a high estimate of $202.61M to a low estimate of $192.54M. As of the current estimate, GoodRx Holdings Inc’s year-ago sales were $195.25MFor the next quarter, 12 analysts are estimating revenue of $198.15M. There is a high estimate of $203.76M for the next quarter, whereas the lowest estimate is $194.1M.
A total of 14 analysts have provided revenue estimates for GDRX’s current fiscal year. The highest revenue estimate was $812.41M, while the lowest revenue estimate was $794.01M, resulting in an average revenue estimate of $798.73M. In the same quarter a year ago, actual revenue was $792.32MBased on 15 analysts’ estimates, the company’s revenue will be $841.92M in the next fiscal year. The high estimate is $871.41M and the low estimate is $816.1M.
